LumaCell
Curated by SignalDeveloper of GPCR-based diagnostics using AI & ML technology
Overview
Developer of GPCR-based diagnostics using AI & ML technology. It offers biosensor-based assays to determine active impairment from THC to manage debilitating chronic diseases like Type 2 diabetes and chronic pain.
Key facts
- Founded
- 2016
- Headquarters
- Washington, United States
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 5 products and services
- Sign up to view
Contact
- Primary office
- Sign up to view